164 results match your criteria: "Card. G. Panico Hospital[Affiliation]"

Left ventricular non-compaction (LVNC) is a rare primary cardiomyopathy with genetic etiology, resulting from an abnormality of myocardial development during embryogenesis. It carries an elevated risk of left ventricular dysfunction, thromboembolic events and malignant arrhythmias. We report the case of LVNC associated with paroxysmal atrial fibrillation and ankyrin 2 () mutation at the genetic test.

View Article and Find Full Text PDF

Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is an alternative to traditional ICDs. The PRAETORIAN score, based on chest radiographs, has been validated to predict the probability of successful S-ICD defibrillation testing by assessing factors like fat thickness between the coil and sternum and generator placement.

Objective: This study evaluated the correlation between the PRAETORIAN score and clinical characteristics, as well as implantation variables.

View Article and Find Full Text PDF

Introduction: In patients with symptomatic, refractory atrial fibrillation the ablate and pace (A&P) strategy (pacemaker implantation followed by atrio-ventricular junction ablation (AVJA)) is superior to medical therapy in improving quality of life and prognosis. Despite its well-proven benefits, this invasive therapeutic option is still underutilized in clinical practice. The choice of pacing modality (right ventricular pacing, biventricular pacing, BVP, or conduction system pacing, CSP) is crucial and can have significant clinical implications.

View Article and Find Full Text PDF

Background And Objective: Left bundle branch area pacing (LBBAP) is increasingly used for treating bradycardia and heart failure. However, real-world data are limited. The Conduction-System Pacing Italian Network Group (C-SING) collected prospective data on LBBAP procedures in a nationwide context.

View Article and Find Full Text PDF
Article Synopsis
  • Pulsed field ablation (PFA) is a new treatment for atrial fibrillation (AF) that shows strong safety and efficacy by specifically targeting heart muscle cells while sparing nearby tissues.
  • A meta-analysis comparing PFA with cryoballoon ablation (CRYO) found that PFA had higher procedural success rates and fewer complications, along with shorter procedural and fluoroscopy times.
  • However, there were no significant differences in major complications or freedom from atrial tachyarrhythmias after one year between the two techniques.
View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzed outcomes of leadless pacemakers (LPMs) in patients with varying stages of chronic kidney disease (CKD) collected from the international i-LEAPER registry, focusing on major complications and electrical performance post-implantation.
  • - Results indicated that while patients with CKD experienced similar rates of major complications during and after LPM implantation compared to those with normal kidney function, all-cause mortality was notably higher in severe CKD stages (G4/G5).
  • - Additionally, patients with CKD displayed a slightly increased pacing threshold during the initial follow-up month, but overall, LPM electrical performance remained comparable across all groups. The research suggests that patients with advanced CKD are less frequently represented in LPM procedures despite
View Article and Find Full Text PDF

Background: Cardiac resynchronization therapy (CRT) represents an effective heart failure treatment, associated with reduction in mortality and heart failure hospitalizations. This Italian survey aimed to address relevant CRT issues.

Methods: An online survey was administered to AIAC members.

View Article and Find Full Text PDF

Atrial fibrillation (AF) is a common cardiac arrhythmia that poses a significant risk of stroke and thromboembolic events. Anticoagulation therapy is essential for preventing stroke in patients with AF. An increasing number of people of all ages, including cardiac patients, approach physical activity as both a leisure-time exercise and a competitive sport.

View Article and Find Full Text PDF

Objective: Irisin, released by muscles during exercise, was recently identified as a neuroprotective factor in mouse models of Alzheimer disease (AD). In a cohort of AD patients, we studied cerebrospinal fluid (CSF) and plasma irisin levels, sex interactions, and correlations with disease biomarkers.

Methods: Correlations between CSF and plasma irisin levels and AD biomarkers (amyloid β 1-42, hyperphosphorylated tau, and total tau [t-tau]) and Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) were analyzed in a cohort of patients with Alzheimer dementia (n = 82), mild cognitive impairment (n = 44), and subjective memory complaint (n = 20) biologically characterized according to the recent amyloid/tau/neurodegeneration classification.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates sex differences in outcomes among recipients of subcutaneous implantable cardioverter-defibrillators (S-ICDs), noting that historically, women have been underrepresented in such trials.
  • Using a multicenter international registry, researchers compared 399 females to a matched cohort of males, focusing on the rate of appropriate shocks and device complications over time.
  • Results showed that women had a lower rate of appropriate shocks compared to men (1.7% vs. 3.4% per year), but no significant difference in device-related complications, indicating that while women are less likely to receive effective ICD therapy, they face no increased risk of adverse effects from the devices.
View Article and Find Full Text PDF

Conduction system pacing (CSP) and atrioventricular junction ablation (AVJA) improve the outcomes in patients with symptomatic, refractory atrial fibrillation (AF). In this setting, AVJA can be performed simultaneously with implantation or in a second procedure a few weeks after implantation. Comparison data on these two alternative strategies are lacking.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers wanted to see if a special heart treatment called catheter ablation (CA) helps patients who have a specific type of heart problem called ventricular tachycardia (VT), especially those with a certain type of defibrillator.
  • They looked at data from patients who had either received a shock from their device or were in the hospital for VT, dividing them into two groups: those who had the treatment and those who didn't.
  • The results showed that patients who had the treatment had fewer heart issues and lower chances of dying from heart problems over time compared to those who didn’t have the treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Conduction system pacing (CSP) combined with atrioventricular junction ablation (AVJA) can effectively treat patients with persistent atrial fibrillation (AF), and a new superior approach (SA) using axillary or subclavian access has been introduced.
  • A study involving 119 patients revealed that the SA significantly reduced nurse workload (NWL) in both the electrophysiology lab and ward compared to the traditional femoral access (FA).
  • Patients undergoing SA reported higher satisfaction levels regarding their hospital experience and overall evaluation than those with FA, highlighting SA as a favorable alternative for these procedures.
View Article and Find Full Text PDF

Background: Cardiac resynchronization therapy (CRT) with biventricular pacing (BVP) is a well-established therapy in patients with reduced left ventricular ejection fraction, heart failure, and left bundle branch block. Left bundle branch area pacing (LBBAP) has recently been shown to be a feasible and effective alternative to BVP. Comparative data on the risk of complications between LBBAP and BVP among patients undergoing CRT are lacking.

View Article and Find Full Text PDF

Introduction: Frontotemporal dementia (FTD) is an extremely heterogeneous and complex neurodegenerative disease, exhibiting different phenotypes, genetic backgrounds, and pathological states. Due to these characteristics, and to the fact that clinical symptoms overlap with those of other neurodegenerative diseases or psychiatric disorders, the diagnosis based only on the clinical evaluation is very difficult. The currently used biomarkers help in the clinical diagnosis, but are insufficient and do not cover all the clinical needs.

View Article and Find Full Text PDF

An 80-years-old patient with permanent atrial fibrillation and symptomatic, paroxysmal atrioventricular blocks (AVBs) underwent leadless pacemaker (L-PM) implantation. Seven years after implantation, as a consequence of a progression of the AVB towards a persistent form, resulting in an increased need for pacing, he developed a pacing-induced cardiomyopathy. He then underwent a successful upgrade from L-PM to a transvenous pacemaker (T-PM) with left bundle branch area pacing (LBBAP).

View Article and Find Full Text PDF

Posterior atlantoaxial screw fixation is a widely adopted therapeutic option for C1-C2 instability secondary to fractures or dislocation, degenerative diseases, or tumors at this level. Anterior transarticular screw fixation (ATSF) is an effective alternative to the posterior approaches, presenting several advantages despite being scarcely known and rarely chosen.In this chapter, we describe the ATSF step by step, illustrating its variations reported in literature, and we critically analyze the several advantages and contraindications of this technique.

View Article and Find Full Text PDF

Introduction: Pure hereditary spastic paraplegia (SPG) type 4 (SPG4) is caused by mutations of gene. This study aimed to analyze variants in SPG4 patients to highlight the occurrence of splicing mutations and combine functional studies to assess the relevance of these variants in the molecular mechanisms of the disease.

Methods: We performed an NGS panel in 105 patients, analysis for splicing mutations, and minigene assay.

View Article and Find Full Text PDF

Introduction: Rhythm control strategy in paroxysmal atrial fibrillation (AF) can be performed with antiarrhythmic drugs (AAD) or catheter ablation (CA). Nevertheless, a clear overview of the percentage of freedom from AF over time and complications is lacking. Therefore, we conducted a -analysis of randomized controlled trials (RCTs) comparing CA versus AAD.

View Article and Find Full Text PDF

Ablate and pace (A&P) with conduction system pacing (CSP) improves outcomes in patients with symptomatic permanent atrial fibrillation (AF). Data on spontaneous sinus rhythm restoration (SSRR) in this setting are lacking. This study aimed to assess the incidence and the predictors of SSRR in a population of patients with permanent AF who underwent A&P with CSP.

View Article and Find Full Text PDF

Background: Conduction system pacing (CSP) and atrioventricular junction ablation (AVJA) improve outcomes in patients with symptomatic, refractory atrial fibrillation (AF). Superior approach (SA) from the pocket via axillary or subclavian vein has been proposed as an alternative to the conventional femoral venous access (FA) to perform AVJA.

Objective: To assess the feasibility and safety of SA for AVJA performed simultaneously with CSP, and to compare this approach with FA.

View Article and Find Full Text PDF
Article Synopsis
  • High-power-short-duration (HPSD) radiofrequency ablation is a promising alternative to low-power-long-duration (LPLD) for isolating pulmonary veins in patients with atrial fibrillation (AF).
  • A meta-analysis of five randomized trials with 424 patients revealed that HPSD significantly reduced AF recurrence rates compared to LPLD and also shortened total procedural time and RF application time.
  • The study found no significant differences in the rates of complications or the effectiveness of first-pass isolation between HPSD and LPLD groups.
View Article and Find Full Text PDF